Influenza Virus
Influenza virus inhibitors are compounds that interfere with the replication and spread of influenza viruses. These inhibitors are vital in researching antiviral strategies, understanding the life cycle of the influenza virus, and developing effective treatments and vaccines. Influenza inhibitors can target various stages of the viral replication process, including viral entry, replication, and release. At CymitQuimica, we offer a diverse range of high-quality influenza virus inhibitors to support your research in virology, infectious diseases, and antiviral drug development.
Found 296 products of "Influenza Virus"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Rimantadine
CAS:<p>Rimantadine (1-Rimantadine) (Flumadine) is an anti-influenza virus drug for T. brucei with IC50 of 7 μM.</p>Formula:C12H21NPurity:98%Color and Shape:SolidMolecular weight:179.3Influenza HA (126-138)
CAS:<p>Influenza HA (126-138), a peptide from the virus's HA protein, induces apoptosis in T-cells.</p>Formula:C52H81N19O22Purity:98%Color and Shape:SolidMolecular weight:1324.31Influenza NP (147-155)
CAS:<p>This peptide is a H-2Kd-restricted epitope from Influenza nucleoprotein (147-155).</p>Formula:C48H82N16O14Purity:98%Color and Shape:SolidMolecular weight:1107.26M2e, human
CAS:<p>M2e, human: a universal vaccine candidate for all human influenza A strains, with 23 conserved extracellular M2 protein residues.</p>Formula:C107H170N32O41S2Purity:98%Color and Shape:SolidMolecular weight:2624.84Dodeca-2E,4E,8Z,10Z/E-N-tetraenoic acid isobutylamide
CAS:<p>Dodeca-2E,4E,8Z,10Z/E-N-tetraenoic acid isobutylamide, a major alkamide in Echinacea preparations and brain-penetrant, may be explored for research on the common cold and various upper respiratory infections [1].</p>Formula:C16H25NOColor and Shape:SolidMolecular weight:247.38Dihydromaniwamycin E
<p>Dihydromaniwamycin E is a heat-shock metabolite exhibiting antiviral activity against influenza and SARS-CoV-2 viruses [1].</p>Formula:C10H22N2O2Color and Shape:SolidMolecular weight:202.29Influenza A NP(366-374) Strain A/PR/8/35
CAS:<p>This peptide is an H2-Db-restricted epitope from the Influenza A/PR/8/34 nucleoprotein.</p>Formula:C38H63N11O18S2Purity:98%Color and Shape:SolidMolecular weight:1026.1Influenza virus-IN-7
CAS:<p>Influenza virus-IN-7: oral endonuclease inhibitor for flu research.</p>Formula:C29H26F2N4O7SColor and Shape:SolidMolecular weight:612.6Influenza A virus-IN-15
<p>Influenza A virus-IN-15 (Compound 9b), a quinoline derivative, is a broad-spectrum anti-influenza inhibitor with an IC50 range of 0.88-6.33 μM and demonstrates acceptable cytotoxicity. It inhibits the transcription and replication of viral RNA, making it suitable for research on Influenza A virus (IAV).</p>Formula:C29H30N6O3Color and Shape:SolidMolecular weight:510.587Maniwamycin E
<p>Maniwamycin E, from Streptomyces sp. JA74, inhibits SARS-CoV-2 and H1N1 viruses.</p>Formula:C10H20N2O2Color and Shape:SolidMolecular weight:200.28CEF4
CAS:<p>CEF4 is a peptide derived from amino acids (aa) 342-351 of the influenza A virus nucleocapsid protein.</p>Formula:C53H93N15O13Purity:98%Color and Shape:SolidMolecular weight:1148.4Neuraminidase-IN-16
<p>Neuraminidase-IN-16 (43b) inhibits H5N1, H5N8, H1N1, H3N2, H5N1-H274Y, H1N1-H274Y neuraminidases; IC50: 0.031-10.08 μM.</p>Formula:C26H35FN2O4Color and Shape:SolidMolecular weight:458.57Influenza A virus-IN-1
CAS:<p>Influenza A virus-IN-1, a dihydropyrrolidone, blocks IAV subtypes (IC50: 3.11-7.13 μM), boosts IFN-β and MxA antivirals.</p>Formula:C27H20F6N2O3Color and Shape:SolidMolecular weight:534.458Influenza HA (307-319)
CAS:<p>Influenza Hemagglutinin is an HLA-DRB 0101-restricted epitope from influenza hemagglutinin (307-319).</p>Formula:C69H118N18O19Purity:98%Color and Shape:SolidMolecular weight:1503.78Anti-IAV agent 1
<p>Anti-IAV agent 1 -1a: Orally active, fights influenza A. IC50: 0.03μM for H1N1, 0.06μM for resistant strains.</p>Formula:C28H28FN9O3Color and Shape:SolidMolecular weight:557.58Herquline A
CAS:<p>Herquline A, a P. herquei alkaloid, blocks influenza A-induced cell death (IC50 = 10 μg/ml) and viral replication; hinders ADP/PAF-induced platelet clumping.</p>Formula:C19H26N2O2Color and Shape:SolidMolecular weight:314.429PROTAC Hemagglutinin Degrader-1
<p>PROTAC Hemagglutinin Degrader-1 (V3) degrades influenza HA potently (DC50 1.44 μM) with broad-spectrum antiviral effects.</p>Formula:C61H93N5O9SColor and Shape:SolidMolecular weight:1072.48CEF1, Influenza Matrix Protein M1 (58-66)
CAS:<p>CEF1, M1 (58-66) epitope from influenza A; GILGFVFTL is HLA-A2-restricted.</p>Formula:C49H75N9O11Purity:98%Color and Shape:SolidMolecular weight:966.17A-315675
CAS:<p>A-315675 is a neuramidase inhibitor with anti-infuenza activity.</p>Formula:C17H30N2O4Color and Shape:SolidMolecular weight:326.43Neuraminidase-IN-12
CAS:<p>NDV-IN-1 is an antiviral inhibiting neuraminidase and the Newcastle disease virus, preventing virion release from Vero cells.</p>Formula:C11H13F3N4O7Color and Shape:SolidMolecular weight:370.24
